ABT
Abbott Laboratories
Stock
$96.69−2.14 (−2.17%)Close Oct 1, 2026
Balance sheet
| Line | Q2 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $5.6B | $8.9B | $8.0B | $7.3B | $10.2B | $10.2B | $7.1B | $4.1B | $4.1B | $9.6B | $18.8B | $6.1B | $4.5B | $8.1B | $15.2B | $8.1B | $7.6B | $11.1B | $6.2B | $2.8B |
| Inventory | $7.3B | $6.5B | $6.2B | $6.6B | $6.2B | $5.2B | $5.0B | $4.3B | $3.8B | $3.6B | $2.4B | $2.6B | $2.6B | $2.7B | $3.8B | $3.3B | $3.2B | $3.3B | $2.8B | $3.0B |
| Current assets | $24.5B | $26.0B | $23.7B | $22.7B | $25.2B | $24.2B | $20.4B | $15.7B | $14.6B | $20.1B | $26.8B | $14.2B | $13.6B | $19.2B | $31.3B | $23.8B | $22.3B | $23.3B | $17.0B | $14.0B |
| Goodwill | $35.2B | $24.0B | $23.1B | $23.7B | $22.8B | $23.2B | $23.7B | $23.2B | $23.3B | $24.0B | $7.7B | $9.6B | $10.1B | $9.8B | $15.8B | $15.7B | $15.9B | $13.2B | $10.0B | $10.1B |
| Intangible assets | $17.2B | $5.5B | $6.6B | $8.8B | $10.5B | $12.7B | $14.8B | $17.0B | $18.9B | $21.5B | $4.5B | $5.6B | $6.2B | $5.7B | $8.6B | $10.0B | $12.2B | $6.3B | $5.2B | $5.7B |
| Total assets | $109.2B | $86.7B | $81.4B | $73.2B | $74.4B | $75.2B | $72.5B | $67.9B | $67.2B | $76.3B | $52.7B | $41.2B | $41.2B | $43.0B | $67.2B | $60.3B | $60.6B | $52.6B | $42.4B | $39.7B |
| Current liabilities | $17.8B | $16.5B | $14.2B | $13.8B | $15.5B | $13.1B | $11.9B | $10.9B | $9.0B | $8.9B | $6.7B | $9.2B | $10.5B | $9.5B | $13.3B | $15.5B | $17.3B | $13.0B | $11.6B | $9.1B |
| Long-term debt | $29.6B | $9.9B | $12.6B | $13.6B | $14.5B | $17.3B | $18.5B | $16.7B | $19.4B | $27.2B | $20.7B | $5.9B | $3.4B | $3.4B | $18.1B | $12.0B | $12.5B | $11.3B | $8.7B | $9.5B |
| Total liabilities | $57.5B | $33.9B | $33.5B | $34.4B | $37.5B | $39.2B | $39.5B | $36.6B | $36.5B | $45.2B | $31.9B | $19.9B | $19.6B | $17.7B | $40.4B | $35.8B | $37.8B | $29.4B | $24.9B | $21.9B |
| Shareholders' equity | $51.1B | $52.1B | $47.7B | $38.6B | $36.7B | $35.8B | $32.8B | $31.1B | $30.5B | $30.9B | $20.5B | $21.2B | $21.5B | $25.2B | $26.7B | $24.4B | $22.7B | $23.1B | $17.5B | $17.8B |
| Shares outstanding | 1.73B | 1.74B | 1.73B | 1.74B | 1.74B | 1.76B | 1.77B | 1.76B | 1.76B | 1.75B | 1.73B | 1.47B | 1.51B | 1.54B | 1.57B | 1.57B | 1.55B | 1.55B | — | — |
| Current ratio | 1.38 | 1.58 | 1.67 | 1.64 | 1.63 | 1.85 | 1.72 | 1.44 | 1.62 | 2.26 | 4.02 | 1.54 | 1.30 | 2.02 | 2.36 | 1.54 | 1.29 | 1.79 | 1.47 | 1.54 |